sanofi buys us haemophilia treatment firm
Last Updated : GMT 05:17:37
Emiratesvoice, emirates voice
Emiratesvoice, emirates voice
Last Updated : GMT 05:17:37
Emiratesvoice, emirates voice

for $11.6 bn

Sanofi buys US haemophilia treatment firm

Emiratesvoice, emirates voice

Emiratesvoice, emirates voice Sanofi buys US haemophilia treatment firm

Sanofi
Paris - Emiratesvoice

French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for haemophilia and rare blood disorders, for $11.6 billion.

Sanofi's chief executive Olivier Brandicourt said the acquisition "enhances its presence in specialty care and leadership in rare diseases... and creates a platform for growth in other rare blood disorders."

The purchase should also translate into a boost in profits per share beginning this year, rising to a gain of up to 5 percent in 2019, Sanofi said in a statement.

Bioverativ has latest-generation treatments for haemophilia, a disorder where blood does not clot properly to stop bleeding.

The haemophilia drugs market is "the largest market in rare diseases", worth around $10 billion per year and projected to grow by seven percent annually over the next five years, Brandicourt said in an audio conference with analysts.

He said he harboured a "strong admiration" for Bioverativ, which is a leader in the field with two drugs, Eloctate and Alprolix, already in the market and estimated overall sales of $1.2 billion in 2017.

Sanofi said it would be able to help Bioverativ with the research it has underway on the development of other haemophilia treatments, as well as for other rare diseases.

The agreement to purchase all of Bioverativ's outstanding shares for $105 each in cash represents a premium of 64 percent from the closing price on Friday, Sanofi said.

The operation is to start in February and close three months later, Brandicourt said.

But investors were not convinced, sending Sanofi's shares sharply lower on the Paris stock exchange as they wondered about the wisdom of putting so much money on the table.

The deal "looks logical, but expensive", with only modest potential to drive growth in the medium term, judged analysts at the Jefferies firm.

Furthermore, Sanofi may run into competition concerns from regulators with the takeover, they said.

The French firm said it would use funds on hand and borrow to finance the acquisition of Bioverativ.

But although pricey, the acquisition will still leave Sanofi with enough financial firepower to go after other acquisition targets, Jefferies said. One such target could be Pfizer's consumer healthcare business, they said.

The purchase of Bioverativ is the largest Sanofi has made since it acquired US biotech firm Genzyme for $20 billion in April 2011.

The French group failed in its 2016 bid to take over US cancer drugmaker Medivation which instead went to Pfizer.

Sanofi shares were 4.2 percent lower at 69.89 euros in late afternoon trading Monday, vastly underperforming the benchmark CAC 40 index in Paris which was up 0.2 percent.

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

sanofi buys us haemophilia treatment firm sanofi buys us haemophilia treatment firm

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

sanofi buys us haemophilia treatment firm sanofi buys us haemophilia treatment firm

 



GMT 10:31 2014 Tuesday ,23 December

Mirages of failure: Lebanon cannot wait

GMT 20:09 2017 Saturday ,16 September

Galaxy Note 8 pre-orders highest among Note series

GMT 20:32 2017 Tuesday ,02 May

Oman health: New hospital opened in Masirah

GMT 08:36 2012 Saturday ,21 January

And we\'re live on BBC Test Match Special

GMT 06:46 2018 Friday ,12 January

Elvis fans all shook up on Australia party train

GMT 09:03 2017 Wednesday ,26 July

13 Taleban killed in Afghanistan airstrike

GMT 06:16 2017 Friday ,29 December

Thai teacher turns to DNA to prove $1m lottery win

GMT 22:39 2017 Friday ,24 November

Mysterious loud booms heard across the world

GMT 07:45 2016 Sunday ,29 May

The world's longest rail tunnel

GMT 11:33 2017 Monday ,07 August

Development of summer tourism

GMT 14:18 2017 Tuesday ,28 November

ZU students publish book about UAE’s Pre-Union Era

GMT 16:32 2017 Friday ,15 September

US enforces visa sanctions as 4 nations

GMT 22:02 2012 Friday ,07 September

Morsi: \'Simple person who loves his country\'

GMT 18:10 2012 Wednesday ,11 April

10-year-old girl gives birth to baby

GMT 07:50 2017 Wednesday ,17 May

Al Ahly Club is keeping Hossam El Badry

GMT 01:10 2017 Sunday ,25 June

Jordan’s GDP expands 2.2pct in Q1

GMT 02:46 2012 Wednesday ,05 September

The experience that taught me there’s life after divorce

GMT 15:07 2012 Wednesday ,07 November

Oriflame to launch Sparkle in Paris collection

GMT 00:21 2017 Saturday ,18 February

Private companies tweak policies to attract Emiratis

GMT 15:55 2017 Wednesday ,13 September

Dubai Land Department to promote Dubai real estate
Emiratesvoice, emirates voice
 
 Emirates Voice Facebook,emirates voice facebook  Emirates Voice Twitter,emirates voice twitter Emirates Voice Rss,emirates voice rss  Emirates Voice Youtube,emirates voice youtube  Emirates Voice Youtube,emirates voice youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

emiratesvoieen emiratesvoiceen emiratesvoiceen emiratesvoiceen
emiratesvoice emiratesvoice emiratesvoice
emiratesvoice
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
emiratesvoice, Emiratesvoice, Emiratesvoice